Dr. Reddy’s Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.
Financial Results:
Dr Reddys Laboratories Ltd reported Revenues for Q2FY25 of ₹8,038.00 Crores up from ₹6,903.00 Crore year on year, a rise of 16.44%.
Total Expenses for Q2FY25 of ₹6,435.00 Crores up from ₹5,305.00 Crores year on year, a rise of 21.3%.
Consolidated Net Profit of ₹1,342.00 Crores down 9.45% from ₹1,482.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹15.05, down 15.31% from ₹17.77 in the same quarter of the previous year.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,